Radical resection of hilar bile duct carcinoma and predictors of survival

Author:

Todoroki T1,Kawamoto T1,Koike N1,Takahashi H2,Yoshida S1,Kashiwagi H1,Takada Y1,Otsuka M1,Fukao K1

Affiliation:

1. Department of Surgery, Institute of Clinical Medicine, University of Tsukuba, Tsukuba 305–8575, Japan

2. Department of Epidemiology and Biostatistics, Institute of Community of Medicine, University of Tsukuba, Tsukuba 305–8575, Japan

Abstract

Abstract Background Patients with carcinoma of the main hepatic duct have a poor prognosis. This study attempted to identify clinicopathological predictors of survival after resection. Methods A retrospective review was performed of 114 patients who presented with hepatic ductal carcinoma between 1976 and 1998. Of the 114 patients, 98 had a radical resection, three underwent palliative resection and 13 were not treated surgically. Forty-six patients with stage IVA disease had microscopic tumour residue after resection. Of these, 28 patients were treated with radiotherapy and the remaining 18 had resection alone. Results The overall operative morbidity and mortality rates were 14 and 4 per cent respectively. The overall 5-year survival rate after resection was 28 per cent. Nineteen patients survived for more than 5 years, including ten with stage IVA disease. The main prognostic factors were performance status; jaundice; tumour location; gross appearance; histological grade; T, N and M categories in tumour node metastasis (TNM) classification; TNM stage; and residual tumour. Adjuvant radiotherapy, tumour extension into the hepatic ducts, histological grade, N and residual tumour were independent predictive factors by multivariate Cox analysis. Conclusion This study suggests that radical resection provides the best survival rate for patients with hilar bile duct carcinoma. For patients with stage IVA disease, following complete gross resection radiotherapy improved treatment outcome.

Publisher

Oxford University Press (OUP)

Subject

Surgery

Reference31 articles.

1. Aggressive surgical treatment of hilar cholangiocarcinoma;Nimura;Journal of Hepato-Biliary-Pancreatic Surgery,1998

2. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis: an unusual tumor with distinctive clinical and pathological features;Klatskin;Am J Med,1965

3. Criteria for the evaluation of direct effects of solid cancer chemotherapy;Furue;Journal of the Japanese Society of Cancer Therapy,1993

4. Biliary Tract IORT

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3